Skip to main content

Meet the Analyst: Thomas Wakim & John Hester, Bell Potter Analyst

Bell Direct
December 17, 2024

Join us as we conclude our 2024 Meet the Analyst series with a bang. Our Market Analyst, Grady Wulff, sits down with Bell Potter’s analysts John Hester and Thomas Wakim for a comprehensive discussion on the healthcare sector.

From deciphering Neuren Pharmaceuticals (ASX:NEU) share price fluctuations to anticipating the news flow that will share 2025 guidance and identifying why Telix Pharmaceuticals (ASX:TLX) and Clarity Pharmaceuticals (ASX:CU6) are stocks to watch in the new year, John and Thomas cover it all in this final episode of the year.

In this video, John and Thomas discuss:

  • (1:48): the headwinds & tailwinds facing the healthcare sector
  • (7:10): why they are bullish on Neuren
  • (13:48): opportunities in healthcare stocks for 2025
  • (15:18): what’s on their clinical data radar for the upcoming year.

Morning Bell 23 September

Paulina Peters
September 23, 2021

Morning Bell 22 September

Jessica Amir
September 22, 2021

Morning Bell 21 September

Jessica Amir
September 21, 2021

Morning Bell 20 September

Jessica Amir
September 20, 2021

Weekly Wrap 17 September

Jessica Amir
September 17, 2021

Morning Bell 17 September

Paulina Peters
September 17, 2021

Morning Bel 16 September

Jessica Amir
September 16, 2021

Morning Bell 15 September

Jessica Amir
September 15, 2021

Morning Bell 14 September

Sophia Mavridis
September 14, 2021

Morning Bell 13 September

Jessica Amir
September 13, 2021

Weekly Wrap 10 September

Jessica Amir
September 10, 2021

Morning Bell 10 September

Sophia Mavridis
September 10, 2021